Print

Immuno-Designed Molecules Signs An R&D Agreement On Anti-Cancer Vaccine With The Walter Reed Army Institute of Research 
10/19/2005 5:12:06 PM

IDM (Immuno-Designed Molecules), a biopharmaceutical company specialized in immunotherapy for the treatment of cancer, announced today the signing of a research and development agreement with the Walter Reed Army Institute of Research located in Silver Spring, Maryland.
//-->